Criteo S.A. (CRTO)

Theseus Pharmaceuticals Stock Forecast

Stock Price Forecast

The 10 analysts that cover Theseus Pharmaceuticals stock have a consensus rating of "Buy" and an average price target of $41.7, which forecasts a 77.45% increase in the stock price over the next year. The lowest target is $27 and the highest is $65.

Price Target: $41.70 (+77.45%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$27	$41.7	$41	$65
Change	+14.89%	+77.45%	+74.47%	+176.60%

Analyst Ratings

The average analyst rating for Theseus Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Feb '25	Mar '25	Apr '25	May '25	Jun '25	Jul '25
Strong Buy	3	3	4	4	4	4
Buy	4	4	3	3	3	3
Hold	4	4	4	4	4	3
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	11	11	11	11	11	10

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Tom White DA Davidson	DA Davidson	Strong Buy Maintains $42 → $38	Strong Buy	Maintains	$42 → $38	+61.70%	Jul 31, 2025
Brian Pitz BMO Capital	BMO Capital	Buy Maintains $49 → $51	Buy	Maintains	$49 → $51	+117.02%	Jul 31, 2025
Alec Brondolo Wells Fargo	Wells Fargo	Buy Maintains $54 → $40	Buy	Maintains	$54 → $40	+70.21%	Jul 29, 2025
John Egbert Stifel	Stifel	Strong Buy Maintains $42 → $41	Strong Buy	Maintains	$42 → $41	+74.47%	Jul 22, 2025
Mark Zgutowicz Benchmark	Benchmark	Strong Buy Maintains $46 → $42	Strong Buy	Maintains	$46 → $42	+78.72%	Jul 22, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

1.18B

Decreased by -39.17%

from 1.93B

Revenue Next Year

1.20B

Increased by 1.87%

from 1.18B

EPS This Year

4.51

Increased by 137.26%

from 1.90

EPS Next Year

4.55

Increased by 1.02%

from 4.51

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	2.07B	2.25B	2.02B	1.95B	1.93B	1.18B	1.20B	1.29B
Revenue Growth	-8.35%	8.76%	-10.52%	-3.35%	-0.83%	-39.17%	1.87%	7.35%
EPS	1.16	2.09	0.14	0.88	1.90	4.51	4.55	5.12
EPS Growth	-15.94%	80.17%	-93.30%	528.57%	115.91%	137.26%	1.02%	12.50%
Forward PE	-	-	-	-	-	5.21	5.16	4.59
No. Analysts	-	-	-	-	-	15	14	7

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	1.2B	1.3B	1.4B
Avg	1.2B	1.2B	1.3B
Low	1.1B	1.1B	1.2B

Revenue Growth

Revenue Growth	2025	2026	2027
High	-36.4%	10.8%	15.3%
Avg	-39.2%	1.9%	7.3%
Low	-42.1%	-5.7%	-0.5%

EPS Forecast

EPS	2025	2026	2027
High	5.06	5.44	6.12
Avg	4.51	4.55	5.12
Low	4.03	4.13	4.43

EPS Growth

EPS Growth	2025	2026	2027
High	166.5%	20.8%	34.4%
Avg	137.3%	1.0%	12.5%
Low	112.0%	-8.5%	-2.7%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.